Placement Completed
AdAlta placement (January 2026)
A$1.2m raised
Announced 13 Jan 2026 · ASX: 1AD
Advisers
AdAlta
Issuer
Not disclosed
Lead managers
- Lead manager
- Issuer
- AdAlta
- Issuer based in
- Australia
- Completed
- 30 Jan 2026
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy, CAR-T
Similar deals
- Liminatus Pharma equity raising Feb 2026 · A$5.7m · Biotech
- Chimeric Therapeutics placement (May 2025) May 2025 · A$6.6m · Biotech
- Obsidian Therapeutics placement Apr 2026 · A$498m · Biotech
- Silexion Therapeutics Corp equity raising A$3.6m · Biotech
- Neurizon Therapeutics placement (September 2025) Sep 2025 · A$5m · Biotech
Sources
- 13 Jan 2026 Overnight strategic placement raises A$1.2 million to advance first-in-class PD1 armored MSLN CAR-T Therapy cdn-api.markitdigital.com
- 30 Jan 2026 Application for quotation of securities - 1AD ASX
